Cargando…

Molecular pathways and therapeutic targets in lung cancer

Lung cancer is still the leading cause of cancer death worldwide. Both histologically and molecularly lung cancer is heterogeneous. This review summarizes the current knowledge of the pathways involved in the various types of lung cancer with an emphasis on the clinical implications of the increasin...

Descripción completa

Detalles Bibliográficos
Autores principales:	Shtivelman, Emma, Hensing, Thomas, Simon, George R., Dennis, Phillip A., Otterson, Gregory A., Bueno, Raphael, Salgia, Ravi
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Impact Journals LLC 2014
Materias:	Review
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4039220/ https://www.ncbi.nlm.nih.gov/pubmed/24722523

Ejemplares similares

A Novel Classification of Lung Cancer into Molecular Subtypes
por: West, Lisandra, et al.
Publicado: (2012)

Molecular pathways and targets in prostate cancer
por: Shtivelman, Emma, et al.
Publicado: (2014)

Pathways and therapeutic targets in melanoma
por: Shtivelman, Emma, et al.
Publicado: (2014)

Fanconi Anemia Repair Pathway Dysfunction, a Potential Therapeutic Target in Lung Cancer
por: Duan, Wenrui, et al.
Publicado: (2014)

EGFR-Targeted Therapeutics: Focus on SCCHN and NSCLC
por: Sattler, Martin, et al.
Publicado: (2008)

Mutation testing for directing upfront targeted therapy and post-progression combination therapy strategies in lung adenocarcinoma
por: Salgia, Ravi
Publicado: (2016)

Synergism of EGFR and c-Met pathways, cross-talk and inhibition, in non-small cell lung cancer
por: Puri, Neelu, et al.
Publicado: (2008)

Targeted agents in non-small cell lung cancer therapy: What is there on the horizon?
por: Villaflor, Victoria M., et al.
Publicado: (2013)

Novel Therapeutic Targets and Immune Dysfunction in Malignant Pleural Mesothelioma
por: Lapidot, Moshe, et al.
Publicado: (2022)

LSD1-targeted therapy—a multi-purpose key to unlock immunotherapy in small cell lung cancer
por: Sattler, Martin, et al.
Publicado: (2023)

Stamp out lung cancer
por: Salgia, Ravi
Publicado: (2008)

Targeting the Complement Pathway as a Therapeutic Strategy in Lung Cancer
por: Kleczko, Emily K., et al.
Publicado: (2019)

MET and PI3K/mTOR as a Potential Combinatorial Therapeutic Target in Malignant Pleural Mesothelioma
por: Kanteti, Rajani, et al.
Publicado: (2014)

The improbable targeted therapy: KRAS as an emerging target in non-small cell lung cancer (NSCLC)
por: Salgia, Ravi, et al.
Publicado: (2021)

Agents to treat BRAF-mutant lung cancer
por: Alvarez, Jean G Bustamante, et al.
Publicado: (2019)

Immunotherapy in inoperable stage III non-small cell lung cancer: a review
por: Jain, Natasha A, et al.
Publicado: (2019)

EphB4 as a therapeutic target in mesothelioma
por: Liu, Ren, et al.
Publicado: (2013)

Fibroblast growth factor signaling and inhibition in non-small cell lung cancer and their role in squamous cell tumors
por: Salgia, Ravi
Publicado: (2014)

The Chicago Thoracic Oncology Database Consortium: A Multisite Database Initiative
por: Won, Brian, et al.
Publicado: (2016)

Bezielle Selectively Targets Mitochondria of Cancer Cells to Inhibit Glycolysis and OXPHOS
por: Chen, Vivian, et al.
Publicado: (2012)

CC3/TIP30 affects DNA damage repair
por: Fong, Sylvia, et al.
Publicado: (2010)

Receptor Tyrosine Kinases and Inhibitors in Lung Cancer
por: Pisick, Evan, et al.
Publicado: (2004)

Small Cell Lung Cancer from Traditional to Innovative Therapeutics: Building a Comprehensive Network to Optimize Clinical and Translational Research
por: Subbiah, Shanmuga, et al.
Publicado: (2020)

KRAS-Mutant Lung Cancer: Targeting Molecular and Immunologic Pathways, Therapeutic Advantages and Restrictions
por: Karimi, Nastaran, et al.
Publicado: (2023)

Molecular markers as therapeutic targets in lung cancer
por: Tseng, Hsin-Hui, et al.
Publicado: (2013)

Advances in epigenetic therapeutics with focus on solid tumors
por: Jin, Ning, et al.
Publicado: (2021)

Protein kinase B phosphorylates AHNAK and regulates its subcellular localization
por: Sussman, Joshua, et al.
Publicado: (2001)

Comprehensive genetic testing identifies targetable genomic alterations in most patients with non-small cell lung cancer, specifically adenocarcinoma, single institute investigation
por: Vigneswaran, Janani, et al.
Publicado: (2016)

Protein Phosphatase 2A as a Therapeutic Target in Small Cell Lung Cancer
por: Mirzapoiazova, Tamara, et al.
Publicado: (2021)

Non-Small Cell Lung Cancer from Genomics to Therapeutics: A Framework for Community Practice Integration to Arrive at Personalized Therapy Strategies
por: Rajurkar, Swapnil, et al.
Publicado: (2020)

Prostate-Associated Gene 4 (PAGE4): Leveraging the Conformational Dynamics of a Dancing Protein Cloud as a Therapeutic Target
por: Salgia, Ravi, et al.
Publicado: (2018)

Glioblastoma: Molecular Pathways, Stem Cells and Therapeutic Targets
por: Jhanwar-Uniyal, Meena, et al.
Publicado: (2015)

Multiple Molecular Pathways in Melanomagenesis: Characterization of Therapeutic Targets
por: Palmieri, Giuseppe, et al.
Publicado: (2015)

Molecular Targets, Pathways, and Therapeutic Implications for Hepatocellular Carcinoma
por: Gong, Jun, et al.
Publicado: (2020)

Molecular Signaling Pathways and Therapeutic Targets in Hepatocellular Carcinoma
por: Dimri, Manali, et al.
Publicado: (2020)

Signaling pathways in macrophages: molecular mechanisms and therapeutic targets
por: Li, Ming, et al.
Publicado: (2023)

Post-crizotinib management of effective ceritinib therapy in a patient with ALK-positive non-small cell lung cancer
por: Won, Brian, et al.
Publicado: (2016)

Combined Checkpoint Inhibition and Chemotherapy: New Era of 1(st)-Line Treatment for Non-Small-Cell Lung Cancer
por: Wang, Chongkai, et al.
Publicado: (2019)

Lung cancer exosomes as drivers of epithelial mesenchymal transition
por: Rahman, Mohammad A., et al.
Publicado: (2016)

Molecular pathways involved in COVID-19 and potential pathway-based therapeutic targets
por: Farahani, Masoumeh, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_a5ql9k7rgm1tjlejqbfptr5csa